412 related articles for article (PubMed ID: 36189293)
1. The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application.
Han X; Zang D; Liu D; Chen J
Front Immunol; 2022; 13():988849. PubMed ID: 36189293
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota shed new light on the management of immune-related adverse events.
Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
[TBL] [Abstract][Full Text] [Related]
3. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis.
Zhou G; Zhang N; Meng K; Pan F
Front Immunol; 2022; 13():1001623. PubMed ID: 36389768
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
Westdorp H; Sweep MWD; Gorris MAJ; Hoentjen F; Boers-Sonderen MJ; van der Post RS; van den Heuvel MM; Piet B; Boleij A; Bloemendal HJ; de Vries IJM
Front Immunol; 2021; 12():768957. PubMed ID: 34777387
[TBL] [Abstract][Full Text] [Related]
5. Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis.
Halsey TM; Thomas AS; Hayase T; Ma W; Abu-Sbeih H; Sun B; Parra ER; Jiang ZD; DuPont HL; Sanchez C; El-Himri R; Brown A; Flores I; McDaniel L; Ortega Turrubiates M; Hensel M; Pham D; Watowich SS; Hayase E; Chang CC; Jenq RR; Wang Y
Sci Transl Med; 2023 Jun; 15(700):eabq4006. PubMed ID: 37315113
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival.
Weingarden AR; Gubatan J; Singh S; Balabanis TC; Patel A; Sharma A; Habtezion A
World J Gastroenterol; 2022 Oct; 28(39):5750-5763. PubMed ID: 36338892
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
Wang J; Zhu N; Su X; Yang R
Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
[TBL] [Abstract][Full Text] [Related]
9. Check this out: treatment paradigms in immune-checkpoint inhibitor colitis.
Kiparizoska S; Murphy ME; Mattar MC
Curr Opin Gastroenterol; 2023 Jan; 39(1):43-49. PubMed ID: 36504035
[TBL] [Abstract][Full Text] [Related]
10. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
Zhao H; Wang D; Zhang Z; Xian J; Bai X
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
12. Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota.
Bouferraa Y; Fares C; Bou Zerdan M; Boyce Kennedy L
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298653
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation for Immune Checkpoint Inhibitor-Induced Colitis Is Safe and Contributes to Recovery: Two Case Reports.
Groenewegen B; Terveer EM; Joosse A; Barnhoorn MC; Zwittink RD
J Immunother; 2023 Jul-Aug 01; 46(6):216-220. PubMed ID: 37216289
[TBL] [Abstract][Full Text] [Related]
14. Correlation of the gut microbiome and immune-related adverse events in gastrointestinal cancer patients treated with immune checkpoint inhibitors.
Zhang Y; Cheng S; Zou H; Han Z; Xie T; Zhang B; Dai D; Yin X; Liang Y; Kou Y; Tan Y; Shen L; Peng Z
Front Cell Infect Microbiol; 2023; 13():1099063. PubMed ID: 37051296
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer.
Chang AE; Golob JL; Schmidt TM; Peltier DC; Lao CD; Tewari M
Trends Cancer; 2021 Jul; 7(7):583-593. PubMed ID: 33741313
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
17. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
19. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis.
Velikova T; Krastev B; Gulinac M; Zashev M; Graklanov V; Peruhova M
World J Clin Cases; 2024 Feb; 12(6):1050-1062. PubMed ID: 38464930
[TBL] [Abstract][Full Text] [Related]
20. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.
Bouferraa Y; Chedid A; Amhaz G; El Lakkiss A; Mukherji D; Temraz S; Shamseddine A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]